6 unchanged sentences
4.1 Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-Q filed on August 5, 2022)
+Added: 10.1(1) QuidelOrtho Corporation 2026 Inducement Plan (incorporated by reference to Exhibit 99.1 to the Registrant’s Form S-8 filed on July 13, 2026)
+Added: 10.2(1)* QuidelOrtho Corporation 2026 Inducement Plan Nonqualified Stock Option Award Agreement
+Added: 10.3(1)* QuidelOrtho Corporation 2026 Inducement Plan Restricted Stock Unit Award Terms and Conditions
+Added: 10.4(1) Employment Offer Letter, dated June 22, 2026, between QuidelOrtho Corporation and Micah Young (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed on June 23, 2026)
+Added: 10.5(1)* Individual Retirement Program for Joseph M.
+Added: Busky, effective as of June 22, 2026
31.1* Certification by Principal Executive Officer of QuidelOrtho Corporation pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
8 unchanged sentences
** Furnished herewith.
+Added: (1) Indicates a management plan or compensatory plan or arrangement.
SUMMARY OF ABBREVIATED TERMS
2 unchanged sentences
Annual Report Annual Report on Form 10-K for the fiscal year ended December 28, 2025
−Removed: AOCI Accumulated other comprehensive loss
+Added: AOCI Accumulated other comprehensive income (loss)
+Added: ASC Accounting Standards Codification
+Added: ASU Accounting Standards Update
Board Board of Directors
8 unchanged sentences
EPS Loss per share
+Added: EU European Union
Exchange Act Securities Exchange Act of 1934, as amended
+Added: FASB Financial Accounting Standards Board
GAAP Generally accepted accounting principles in the U.S.
4 unchanged sentences
JPAC Japan and Asia Pacific
+Added: LEX Diagnostics
+Added: LEX Diagnostics Limited
One Big Beautiful Bill Act
2 unchanged sentences
Ortho Ortho Clinical Diagnostics Holdings plc
−Removed: Quarterly Report Quarterly Report on Form 10-Q for the quarter ended March 29, 2026
+Added: Quarterly Report Quarterly Report on Form 10-Q for the quarter ended June 28, 2026
R&D Research and development
14 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: May 5, 2026 QUIDELORTHO CORPORATION
+Added: August 6, 2026 QUIDELORTHO CORPORATION
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: /s/ JOSEPH M.
+Added: /s/ MICAH YOUNG
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.